Auweiler, Philipp W.P.; Muller, Dirk Mller; Stock, Stephanie - In: PharmacoEconomics 30 (2012) 7, pp. 537-549
Background:Background: The monoclonal antibody rituximab has shown clinical effectiveness in combination with chemotherapy for the treatment of non-Hodgkin's lymphoma (NHL) in several randomized controlled studies. Rituximab maintenance therapy is associated with significant improvement in...